Migration inhibition of endothelial cells by lymphokine-containing supernatants. 1982

M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen

Many of the reactions of cellular immunity are mediated by soluble lymphocyte-derived factors (lymphokines). One important category of lymphokine action involves effects on cell motility. These effects have been described mainly with respect to inflammatory cells. In this report, we describe the ability of a lymphocyte product to inhibit the migration of endothelial cells in a system in vitro. The responsible factor is distinct from a previously described mediator that inhibits the migration of tumor cells. The ability of lymphocytes to influence the migration properties of endothelial cells is consistent with data of others showing a relation between the immune system and processes involving neovascularization.

UI MeSH Term Description Entries
D007961 Leukocyte Migration-Inhibitory Factors Protein factor(s) released by sensitized lymphocytes (and possibly other cells) that inhibit the movement of LEUKOCYTES, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the LEUKOCYTE MIGRATION CAPILLARY TUBE TECHNIQUE (LMCT) and the LEUKOCYTE MIGRATION AGAROSE TEST (LMAT). Migration-Inhibition Factors, Leukocyte,Leukocyte Migration-Inhibition Factors,Migration-Inhibitory Factors, Leukocyte,Factors, Leukocyte Migration-Inhibition,Factors, Leukocyte Migration-Inhibitory,Leukocyte Migration Inhibition Factors,Leukocyte Migration Inhibitory Factors,Migration Inhibition Factors, Leukocyte,Migration Inhibitory Factors, Leukocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012515 Mast-Cell Sarcoma A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow. Mastocytoma, Malignant,Sarcoma, Mast-Cell,Malignant Mastocytoma,Malignant Mastocytomas,Mast Cell Sarcoma,Mast-Cell Sarcomas,Mastocytomas, Malignant,Sarcoma, Mast Cell,Sarcomas, Mast-Cell

Related Publications

M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
September 1978, Journal of immunology (Baltimore, Md. : 1950),
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
May 1975, Journal of immunology (Baltimore, Md. : 1950),
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
January 1981, Journal of immunology (Baltimore, Md. : 1950),
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
December 1985, Clinical rheumatology,
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
November 1989, Immunology letters,
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
September 1984, Cancer research,
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
May 1994, Cancer immunology, immunotherapy : CII,
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
October 1983, Journal of immunology (Baltimore, Md. : 1950),
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
June 1988, European journal of clinical investigation,
M C Cohen, and P T Picciano, and W J Douglas, and T Yoshida, and D L Kreutzer, and S Cohen
October 1980, Experimental and molecular pathology,
Copied contents to your clipboard!